Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2

Pavoni, Vittorio; Gianesello, Lara

doi:10.1007/s11239-020-02115-6

Cited by 2 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thrombocytosis may be induced by thrombopoietin, released in the presence of pro-inflammatory cytokines such as IL-6 ( 85 ). Platelet count elevation was reported as a distinctive feature in SARS-CoV-2-induced pneumonia vs. other etiologies ( 86 ). There is a low risk of venous and arterial thrombus formation following reactive thrombocytosis ( 87 , 88 ).…”

Section: Factors Associated With Stroke In Patients Infected With Sars-cov-2mentioning

confidence: 99%

Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology

Neshin

Shahjouei

Koza

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Since the early days of the pandemic, there have been several reports of cerebrovascular complications during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Numerous studies proposed a role for SARS-CoV-2 in igniting stroke. In this review, we focused on the pathoetiology of stroke among the infected patients. We pictured the results of the SARS-CoV-2 invasion to the central nervous system (CNS) via neuronal and hematogenous routes, in addition to viral infection in peripheral tissues with extensive crosstalk with the CNS. SARS-CoV-2 infection results in pro-inflammatory cytokine and chemokine release and activation of the immune system, COVID-19-associated coagulopathy, endotheliitis and vasculitis, hypoxia, imbalance in the renin-angiotensin system, and cardiovascular complications that all may lead to the incidence of stroke. Critically ill patients, those with pre-existing comorbidities and patients taking certain medications, such as drugs with elevated risk for arrhythmia or thrombophilia, are more susceptible to a stroke after SARS-CoV-2 infection. By providing a pictorial narrative review, we illustrated these associations in detail to broaden the scope of our understanding of stroke in SARS-CoV-2-infected patients. We also discussed the role of antiplatelets and anticoagulants for stroke prevention and the need for a personalized approach among patients with SARS-CoV-2 infection.

show abstract

Section: Factors Associated With Stroke In Patients Infected With Sars-cov-2mentioning

confidence: 99%

Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology

Neshin

Shahjouei

Koza

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“Bowel Gangrene-an Unusual Presentation of Covid 19”

Bhat¹,

Gupta²,

Goel³

2021

ijsr

View full text Add to dashboard Cite

The Covid 19 disease caused by novel corona virus was rst reported in Wuhan, China in December 2019 with 5% patients having severe lung injury. Though this disease primilary presents as the lower respiratory tract infection, multiple digestive manifestation have been reported which are often overlooked. The present case report describes the unusual progression of the Covid 19 disease from pneumonia to a procoagulant state leading to abdominal venous thrombosis and subsequent gut ischemia necessitating emergency laparotomy.

show abstract

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2

Cited by 2 publications

References 7 publications

Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology

Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology

“Bowel Gangrene-an Unusual Presentation of Covid 19”

Contact Info

Product

Resources

About